APO RESEARCH · REPORT
Biomarkers
In biological system, it means to calculate the whole number by marking part of individuals.
Product & engineering
Understand the product.
In biological system, it means to calculate the whole number by marking part of individuals.
Selected research
Market Structure
Global Biomarkers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
In biological system, it means to calculate the whole number by marking part of individuals.
North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.
Report Includes
Read the full market overview
This report provides an overview of the global Biomarkers market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biomarkers and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biomarkers revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biomarkers market size, projected growth trends, production technologies, key applications, and end-use industries.
Biomarkers Segment by Company
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Biomarkers Segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other
Biomarkers Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Other
Biomarkers Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarkers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biomarkers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomarkers industry.
Chapter 3: Detailed analysis of Biomarkers companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomarkersrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sepsis Biomarkers
- Antibiotic Resistance Biomarkers
- Traumatic Brain Injury (TBI) Testing Biomarkers
- Stroke Testing Biomarkers
- Antibiotic Stewardship Biomarkers
- Other
Applications
- Diagnostics
- Drug Discovery
- Personalized Medicine
- Other
Companies covered
- Thermo Fisher Scientific
- Merck
- Bio-Rad Laboratories
- QIAGEN
- Roche
- Danaher Corporation
- Siemens Healthcare
- Abbott
- Agilent Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Biomarkers Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Sepsis Biomarkers
- 1.2.3 Antibiotic Resistance Biomarkers
- 1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
- 1.2.5 Stroke Testing Biomarkers
- 1.2.6 Antibiotic Stewardship Biomarkers
- 1.2.7 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Biomarkers Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Diagnostics
- 1.3.3 Drug Discovery
- 1.3.4 Personalized Medicine
- 1.3.5 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Biomarkers Growth Trends by Region
- 1.5.1 Global Biomarkers Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Biomarkers Market Size by Region (2021-2026)
- 1.5.3 Biomarkers Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Biomarkers Market Dynamics
- 2.1 Biomarkers Industry Trends
- 2.2 Biomarkers Industry Drivers
- 2.3 Biomarkers Industry Opportunities and Challenges
- 2.4 Biomarkers Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Biomarkers Revenue by Company (2021-2026)
- 3.2 Global Biomarkers Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Biomarkers Key Company Head office and Area Served
- 3.4 Global Biomarkers Company, Product Type & Application
- 3.5 Global Biomarkers Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Biomarkers Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Biomarkers Players Market Share by Revenue in 2025
- 3.6.3 2025 Biomarkers Tier 1, Tier 2, and Tier 3
4 Biomarkers Market by Type
- 4.1 Global Biomarkers Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Biomarkers Market Size by Type (2021-2032)
- 4.3 Global Biomarkers Market Size Share by Type (2021-2032)
5 Biomarkers Market by Application
- 5.1 Global Biomarkers Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Biomarkers Market Size by Application (2021-2032)
- 5.3 Global Biomarkers Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Thermo Fisher Scientific Biomarkers Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Merck Biomarkers Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Bio-Rad Laboratories
- 6.3.1 Bio-Rad Laboratories Company Information
- 6.3.2 Bio-Rad Laboratories Business Overview
- 6.3.3 Bio-Rad Laboratories Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Bio-Rad Laboratories Biomarkers Product Portfolio
- 6.3.5 Bio-Rad Laboratories Recent Developments
- 6.4 QIAGEN
- 6.4.1 QIAGEN Company Information
- 6.4.2 QIAGEN Business Overview
- 6.4.3 QIAGEN Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 QIAGEN Biomarkers Product Portfolio
- 6.4.5 QIAGEN Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Roche Biomarkers Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 Danaher Corporation
- 6.6.1 Danaher Corporation Company Information
- 6.6.2 Danaher Corporation Business Overview
- 6.6.3 Danaher Corporation Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Danaher Corporation Biomarkers Product Portfolio
- 6.6.5 Danaher Corporation Recent Developments
- 6.7 Siemens Healthcare
- 6.7.1 Siemens Healthcare Company Information
- 6.7.2 Siemens Healthcare Business Overview
- 6.7.3 Siemens Healthcare Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Siemens Healthcare Biomarkers Product Portfolio
- 6.7.5 Siemens Healthcare Recent Developments
- 6.8 Abbott
- 6.8.1 Abbott Company Information
- 6.8.2 Abbott Business Overview
- 6.8.3 Abbott Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Abbott Biomarkers Product Portfolio
- 6.8.5 Abbott Recent Developments
- 6.9 Agilent Technologies
- 6.9.1 Agilent Technologies Company Information
- 6.9.2 Agilent Technologies Business Overview
- 6.9.3 Agilent Technologies Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Agilent Technologies Biomarkers Product Portfolio
- 6.9.5 Agilent Technologies Recent Developments
7 North America
- 7.1 North America Biomarkers Market Size (2021-2032)
- 7.2 North America Biomarkers Market Size by Type
- 7.2.1 North America Biomarkers Market Size by Type (2021-2026)
- 7.2.2 North America Biomarkers Market Size by Type (2027-2032)
- 7.2.3 North America Biomarkers Market Share by Type (2021-2032)
- 7.3 North America Biomarkers Market Size by Application
- 7.3.1 North America Biomarkers Market Size by Application (2021-2026)
- 7.3.2 North America Biomarkers Market Size by Application (2027-2032)
- 7.3.3 North America Biomarkers Market Share by Application (2021-2032)
- 7.4 North America Biomarkers Market Size by Country
- 7.4.1 North America Biomarkers Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Biomarkers Market Size by Country (2021-2026)
- 7.4.3 North America Biomarkers Market Size by Country (2027-2032)
- 7.4.4 North America Biomarkers Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Biomarkers Market Size (2021-2032)
- 8.2 Europe Biomarkers Market Size by Type
- 8.2.1 Europe Biomarkers Market Size by Type (2021-2026)
- 8.2.2 Europe Biomarkers Market Size by Type (2027-2032)
- 8.2.3 Europe Biomarkers Market Share by Type (2021-2032)
- 8.3 Europe Biomarkers Market Size by Application
- 8.3.1 Europe Biomarkers Market Size by Application (2021-2026)
- 8.3.2 Europe Biomarkers Market Size by Application (2027-2032)
- 8.3.3 Europe Biomarkers Market Share by Application (2021-2032)
- 8.4 Europe Biomarkers Market Size by Country
- 8.4.1 Europe Biomarkers Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Biomarkers Market Size by Country (2021-2026)
- 8.4.3 Europe Biomarkers Market Size by Country (2027-2032)
- 8.4.4 Europe Biomarkers Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Biomarkers Market Size (2021-2032)
- 9.2 China Biomarkers Market Size by Type
- 9.2.1 China Biomarkers Market Size by Type (2021-2026)
- 9.2.2 China Biomarkers Market Size by Type (2027-2032)
- 9.2.3 China Biomarkers Market Share by Type (2021-2032)
- 9.3 China Biomarkers Market Size by Application
- 9.3.1 China Biomarkers Market Size by Application (2021-2026)
- 9.3.2 China Biomarkers Market Size by Application (2027-2032)
- 9.3.3 China Biomarkers Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Biomarkers Market Size (2021-2032)
- 10.2 Asia Biomarkers Market Size by Type
- 10.2.1 Asia Biomarkers Market Size by Type (2021-2026)
- 10.2.2 Asia Biomarkers Market Size by Type (2027-2032)
- 10.2.3 Asia Biomarkers Market Share by Type (2021-2032)
- 10.3 Asia Biomarkers Market Size by Application
- 10.3.1 Asia Biomarkers Market Size by Application (2021-2026)
- 10.3.2 Asia Biomarkers Market Size by Application (2027-2032)
- 10.3.3 Asia Biomarkers Market Share by Application (2021-2032)
- 10.4 Asia Biomarkers Market Size by Country
- 10.4.1 Asia Biomarkers Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Biomarkers Market Size by Country (2021-2026)
- 10.4.3 Asia Biomarkers Market Size by Country (2027-2032)
- 10.4.4 Asia Biomarkers Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Biomarkers Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Biomarkers Market Size by Type
- 11.2.1 South America, Middle East & Africa Biomarkers Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Biomarkers Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Biomarkers Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Biomarkers Market Size by Application
- 11.3.1 South America, Middle East & Africa Biomarkers Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Biomarkers Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Biomarkers Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Biomarkers Market Size by Country
- 11.4.1 South America, Middle East & Africa Biomarkers Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Biomarkers Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Biomarkers Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Biomarkers Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst